ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
The National Institutes of Health rolled out a pair of initiatives on Feb. 8 to determine the genetic and environmental underpinnings of common diseases. The Genes & Environment Initiative (GEI) and the Genetics Association Information Network (GAIN) are multiyear efforts that will focus on genetic variations known as single-nucleotide polymorphisms.
GEI is planned to begin in 2007 with a requested funding level of $68 million. The initiative will combine genotyping with environmental toxicology studies to elucidate the causes of as many as a dozen common diseases that will be determined later by peer review.
A public-private partnership, GAIN brings together NIH, the Foundation for the National Institutes of Health, Pfizer, and Affymetrix to accelerate genetic association studies. Pfizer has donated $5 million to set up a management structure and $15 million worth of laboratory studies to determine the genetic contributions to five common diseases. Affymetrix will contribute analytical resources worth an estimated $6 million.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X